These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18186046)
1. Evaluation of cell affinity on poly(L-lactide) and poly(epsilon-caprolactone) blends and on PLLA-b-PCL diblock copolymer surfaces. Ajami-Henriquez D; Rodríguez M; Sabino M; Castillo RV; Müller AJ; Boschetti-de-Fierro A; Abetz C; Abetz V; Dubois P J Biomed Mater Res A; 2008 Nov; 87(2):405-17. PubMed ID: 18186046 [TBL] [Abstract][Full Text] [Related]
2. Preparation of lotus-leaf-like structured blood compatible poly(ε-caprolactone)-block-poly(L-lactic acid) copolymer film surfaces. Kim SI; Lim JI; Lee BR; Mun CH; Jung Y; Kim SH Colloids Surf B Biointerfaces; 2014 Feb; 114():28-35. PubMed ID: 24161503 [TBL] [Abstract][Full Text] [Related]
3. Biodegradable films of partly branched poly(l-lactide)-co-poly(epsilon-caprolactone) copolymer: modulation of phase morphology, plasticization properties and thermal depolymerization. Broström J; Boss A; Chronakis IS Biomacromolecules; 2004; 5(3):1124-34. PubMed ID: 15132708 [TBL] [Abstract][Full Text] [Related]
4. Compatibilization effect of poly(epsilon-caprolactone)-b-poly(ethylene glycol) block copolymers and phase morphology analysis in immiscible poly(lactide)/poly(epsilon-caprolactone) blends. Na YH; He Y; Shuai X; Kikkawa Y; Doi Y; Inoue Y Biomacromolecules; 2002; 3(6):1179-86. PubMed ID: 12425654 [TBL] [Abstract][Full Text] [Related]
5. Investigation of PLLA/PCL blends and paclitaxel release profiles. Can E; Udenir G; Kanneci AI; Kose G; Bucak S AAPS PharmSciTech; 2011 Dec; 12(4):1442-53. PubMed ID: 22038476 [TBL] [Abstract][Full Text] [Related]
6. Development, characterization, and cellular adhesion of poly(L-lactic acid)/poly(caprolactone triol) membranes for potential application in bone tissue regeneration. Mistura DV; Messias AD; Duek EA; Duarte MA Artif Organs; 2013 Nov; 37(11):978-84. PubMed ID: 24237398 [TBL] [Abstract][Full Text] [Related]
7. Phase structure and enzymatic degradation of poly(L-lactide)/atactic poly(3-hydroxybutyrate) blends: an atomic force microscopy study. Kikkawa Y; Suzuki T; Tsuge T; Kanesato M; Doi Y; Abe H Biomacromolecules; 2006 Jun; 7(6):1921-8. PubMed ID: 16768415 [TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymers with nanophase separation. Hsu SH; Tang CM; Lin CC Biomaterials; 2004 Nov; 25(25):5593-601. PubMed ID: 15159075 [TBL] [Abstract][Full Text] [Related]
9. In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. Kim MS; Kim SK; Kim SH; Hyun H; Khang G; Lee HB Tissue Eng; 2006 Oct; 12(10):2863-73. PubMed ID: 17518655 [TBL] [Abstract][Full Text] [Related]
10. Formation of and coalescence from the inclusion complex of a biodegradable block copolymer and alpha-cyclodextrin. 2: A novel way to regulate the biodegradation behavior of biodegradable block copolymers. Shuai X; Wei M; Porbeni FE; Bullions TA; Tonelli AE Biomacromolecules; 2002; 3(1):201-7. PubMed ID: 11866574 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable polyesters as crystallization-accelerating agents of poly(l-lactide). Tsuji H; Sawada M; Bouapao L ACS Appl Mater Interfaces; 2009 Aug; 1(8):1719-30. PubMed ID: 20355788 [TBL] [Abstract][Full Text] [Related]
13. New generation poly(ε-caprolactone)/gel-derived bioactive glass composites for bone tissue engineering: Part I. Material properties. Dziadek M; Menaszek E; Zagrajczuk B; Pawlik J; Cholewa-Kowalska K Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():9-21. PubMed ID: 26249560 [TBL] [Abstract][Full Text] [Related]
14. Controlled preparation and properties of porous poly(L-lactide) obtained from a co-continuous blend of two biodegradable polymers. Sarazin P; Roy X; Favis BD Biomaterials; 2004 Dec; 25(28):5965-78. PubMed ID: 15183611 [TBL] [Abstract][Full Text] [Related]
15. Composition dependence of the crystallization behavior and morphology of the poly(ethylene oxide)-poly(epsilon-caprolactone) diblock copolymer. He C; Sun J; Ma J; Chen X; Jing X Biomacromolecules; 2006 Dec; 7(12):3482-9. PubMed ID: 17154478 [TBL] [Abstract][Full Text] [Related]
16. Immiscible poly(lactic acid)/poly(ε-caprolactone) for temporary implants: Compatibility and cytotoxicity. Finotti PF; Costa LC; Capote TS; Scarel-Caminaga RM; Chinelatto MA J Mech Behav Biomed Mater; 2017 Apr; 68():155-162. PubMed ID: 28171812 [TBL] [Abstract][Full Text] [Related]
17. Selective enzymatic degradations of poly(L-lactide) and poly(epsilon-caprolactone) blend films. Liu L; Li S; Garreau H; Vert M Biomacromolecules; 2000; 1(3):350-9. PubMed ID: 11710123 [TBL] [Abstract][Full Text] [Related]
18. Compatibilized polymer blends based on PDLLA and PCL for application in bioartificial liver. Calandrelli L; Calarco A; Laurienzo P; Malinconico M; Petillo O; Peluso G Biomacromolecules; 2008 Jun; 9(6):1527-34. PubMed ID: 18494521 [TBL] [Abstract][Full Text] [Related]
19. [Research on cell affinity of poly-L-lactide/porcine-derived xenogeneic bone composite in vitro]. Qu X; Bei J; Wang S Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):110-4. PubMed ID: 17357454 [TBL] [Abstract][Full Text] [Related]
20. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(epsilon-caprolactone) blends for tissue engineering applications in the form of hollow fibers. Chiono V; Ciardelli G; Vozzi G; Sotgiu MG; Vinci B; Domenici C; Giusti P J Biomed Mater Res A; 2008 Jun; 85(4):938-53. PubMed ID: 17896770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]